First-of-its-kind treatment for Acute Lymphoblastic Leukemia developed

Tata Memorial, IDRS Labs develop an oral suspension to be available soon

geetanjali

Geetanjali Minhas | December 29, 2023 | Mumbai


#Health   #Healthcare   #cancer  


Tata Memorial Hospital, Mumbai, the Advanced Centre for Training Research and Education in Cancer (ACTREC), Navi Mumbai along with IDRS Labs, Bangalore have developed an oral suspension of 6-mercaptopurine (6-MP) in India. 6-MP is a chemotherapy drug used in the treatment of acute lymphoblastic leukemia (ALL), the most common type of blood cancer afflicting children.

The first and only child-friendly formulation is available in the form of a powder for oral suspension, and marketed under the tradename ‘PREVALL’.

PREVALL can be reconstituted into 100 ml oral suspension at a concentration of 10mg/ml. It is available with a syringe and a press in bottle adapter (PIBA) for precise dosing tailored to the patient’s body weight or body surface area.

It has been approval by the Central Drugs Standard Control Organization (CDSCO) under the ministry of health and family welfare, government of India. Tata Memorial Centre and IDRS Labs jointly published the results of the clinical study that lead to regulatory approval in the scientific journal Pediatric Blood and Cancer recently.

PREVALL, the dry powder pharmaceutical suspension of 6-mercaptopurine, is a patented technology of IDRS Labs Private Limited and will be available in all major hospital pharmacies across the country very soon. Approximately 10,000 children in the age group of 1-10 years diagnosed with ALL are expected to benefit from PREVALL each year.

Dr. Vikram, Professor of Clinical Pharmacology, ACTREC, said that the powder for oral suspension is designed to ensure stability of the drug in hot/humid conditions and is quite distinct from the liquid formulation available elsewhere in the world.

Dr. Sudeep Gupta, Director, Tata Memorial Centre, Mumbai, said that TMC is committed to fostering innovation, citing the example of CAR-T cell therapy  which was also pioneered by TMC recently in a similar collaborative effort.

Dr. Ajit Kumar Mohanty, Secretary Department of Atomic Energy, and Chairman, Atomic Energy Commission, said the development is an outcome of the convergence of academia and industry interests to bridge the gap between unmet need and innovation in healthcare.
 

Comments

 

Other News

When algorithms decide and children die

The images have not left me, of dead and wounded children being carried in the arms of the medics and relatives to the ambulances and hospitals. On February 28, at the start of Operation Epic Fury, cruise missiles struck the Shajareh Tayyebeh school – officially named a girls’ school, in Minab,

The economics of representation: Why women in power matter

India’s democracy has grown in scale, but not quite in balance. Women today are active participants in elections, influencing outcomes in ways that were not as visible earlier. Yet their presence in legislative institutions continues to lag behind. The Nari Shakti Vandan Adhiniyam was meant to addres

India will be powerful, not aggressive: Bhaiyyaji

India is poised to emerge as a global power but will remain rooted in its civilisational ethos of non-aggression and harmony, former RSS General Secretary Suresh `Bhaiyyaji` Joshi has said.   He was speaking at the launch of “Rashtrabhav,” a book by Ravindra Sathe

AI: Code, Control, Conquer

India today stands at a critical juncture in the area of artificial intelligence. While the country is among the fastest adopters of AI in the world, it remains heavily reliant on technologies developed elsewhere. This paradox, experts warn, cannot persist if India seeks technological sovereignty.

RBI pauses to assess inflation risks, policy transmission

The Reserve Bank of India (RBI) has begun the new fiscal year with a calibrated pause, keeping the repo rate unchanged at 5.25 per cent in its April Monetary Policy Committee (MPC) meeting. The decision, taken unanimously, reflects a shift from aggressive policy action to cautious observation after a signi

New pathways for tourism growth

Traditionally, India’s tourism policy has been based on three main components: the number of visitors, building tourist attractions and providing facilities for tourists. Due to the increase in climate-related issues and environmental destruction that occurred over previous years, policymakers have b


Archives

Current Issue

Opinion

Facebook Twitter Google Plus Linkedin Subscribe Newsletter

Twitter